Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient

J Cardiothorac Surg. 2020 Mar 26;15(1):52. doi: 10.1186/s13019-020-01092-4.

Abstract

Background: Esophageal squamous cell carcinoma with tumor thrombus in the arch of the azygos vein has not been reported to date. Neoadjuvant chemotherapy can decrease the stage in patients with advanced preoperative tumor staging, regaining surgical opportunities and significantly prolonging progression-free survival and overall survival. Herein, we present a case of esophageal squamous cell carcinoma accompanied by tumor thrombus in the arch of the azygos vein, and the patient underwent radical surgery after neoadjuvant chemotherapy.

Case presentation: A 63-year-old male with esophageal squamous cell carcinoma was found to have tumor thrombus formation in the arch of the azygos vein. Four courses of neoadjuvant chemotherapy with the TP regimen (paclitaxel plus nedaplatin) were given. Reexamination revealed a significant reduction in tumor and tumor thrombus volume. Therefore, McKeown radical resection for esophageal cancer and removal of the tumor thrombus in the arch of the azygos vein were performed. Postoperative pathology suggested complete remission of the esophageal tumor and the presence of small focal cancer tissues in the arch of the azygos vein.

Conclusion: We report a case of esophageal squamous cell carcinoma with tumor thrombus formation in the azygos vein. We conducted radical resection after 4 rounds of neoadjuvant chemotherapy, and the pathological results revealed complete remission of the tumor. We report our experience addressing this rare case, and we hope to find the underlying mechanism of tumor thrombus formation and whether it has any effects on prognosis in our future study.

Keywords: Azygos vein; Esophageal squamous cell carcinoma; Neoadjuvant chemotherapy; Tumor thrombus.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Azygos Vein / surgery*
  • Chemotherapy, Adjuvant
  • Esophageal Neoplasms / complications
  • Esophageal Neoplasms / drug therapy
  • Esophageal Neoplasms / surgery*
  • Esophageal Squamous Cell Carcinoma / complications
  • Esophageal Squamous Cell Carcinoma / drug therapy
  • Esophageal Squamous Cell Carcinoma / surgery*
  • Esophagectomy
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Organoplatinum Compounds / administration & dosage
  • Paclitaxel / administration & dosage
  • Thrombosis / etiology
  • Thrombosis / surgery*

Substances

  • Organoplatinum Compounds
  • nedaplatin
  • Paclitaxel